bioRxiv Science⌕ Search

Biology subjects

Graziani, M.

Publications and source records attributed to Graziani, M..

2 recordsLinked to original sources

Signature Informed Sampling for Transcriptomic Data

With machine learning taking over biomedical applications, working with transcriptomic data on supervised learning tasks is challenging due to high dimensionality, low patient numbers and class imbalances. Machine learning models tend to overfit these data and do not generalise well on out-of-distribution samples. Data augmentation strategies help alleviate this by introducing synthetic data points and acting as regularisers. However, existing approaches are either computationally intensive, require population parametric estimates or generate insufficiently diverse samples. To address these challenges, we introduce two classes of phenotype driven data augmentation approaches - signature-dependent and signature-independent. The signature-dependent methods assume the existence of distinct gene signatures describing some phenotype and are simple, non-parametric, and novel data augmentation methods. The signature-independent methods are a modification of the established Gamma-Poisson and Poisson sampling methods for gene expression data. As case studies, we apply our augmentation methods to transcriptomic data of colorectal and breast cancer. Through discriminative and generative experiments with external validation, we show that our methods improve patient stratification by 5 - 15% over other augmentation methods in different cases. The study additionally provides insights into the limited benefits of over-augmenting data. The code is hosted on GitHub, and includes a link to the augmented datasets.

bioinformatics↗

HIV-1 infection of genetically engineered iPSC-derived central nervous system-engrafted microglia in a humanized mouse model

The central nervous system (CNS) is a major human immunodeficiency virus type 1 reservoir. Microglia are the primary target cell of HIV-1 infection in the CNS. Current models have not allowed the precise molecular pathways of acute and chronic CNS microglial infection to be tested with in vivo genetic methods. Here, we describe a novel humanized mouse model utilizing human-induced pluripotent stem cell-derived microglia to xenograft into murine hosts. These mice are additionally engrafted with human peripheral blood mononuclear cells that served as a medium to establish a peripheral infection that then spread to the CNS microglia xenograft, modeling a trans-blood-brain barrier route of acute CNS HIV-1 infection with human target cells. The approach is compatible with iPSC genetic engineering, including inserting targeted transgenic reporter cassettes to track the xenografted human cells, enabling the testing of novel treatment and viral tracking strategies in a comparatively simple and cost-effective way vivo model for neuroHIV. ImportanceOur mouse model is a powerful tool for investigating the genetic mechanisms governing CNS HIV-1 infection and latency in the CNS at a single-cell level. A major advantage of our model is that it uses iPSC-derived microglia, which enables human genetics, including gene function and therapeutic gene manipulation, to be explored in vivo, which is more challenging to study with current hematopoietic stem cell-based models for neuroHIV. Our transgenic tracing of xenografted human cells will provide a quantitative medium to develop new molecular and epigenetic strategies for reducing the HIV-1 latent reservoir and to test the impact of therapeutic inflammation-targeting drug interventions on CNS HIV-1 latency.

neuroscience↗